Clinical Trials Browser

Phase 2 × Rectal Cancer Patients × Bevacizumab × Clear all

NCT01426074 2018-08-21

DCE-MRI PET Bevacizumab Study in Rectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Rectal Cancer Patients